Small Cap Voice

Progressive Care Shareholder Conference Call and Business Update November 14, 2022. Co-vice chairman and CEO, Alan Jay Weisberg, stated, “It has been an exciting quarter for the company and we are really looking forward to sharing developments with our shareholders.”

Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.

SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with David Massey, CEO of Solar Integrated Roofing Corp. (OTC:SIRC), to discuss the Company’s recent news, financial position and other points of shareholder interest.

SIRC is an alternative energy company that specializes in commercial and residential projects throughout the United States. Utilizing a successful growth-by-acquisition strategy, the Company’s breadth of offerings has expanded to include sales and installation of solar energy systems, battery backup and electric vehicles (EV) charging stations to roofing, HVAC and related electrical contracting work.

Speaking with SCV’s Stuart Smith, Massey outlines SIRC’s five revenue streams and their contribution to the Company’s record second-quarter performance, where it grew its revenues by 746 percent to $66.3 million with net income of $18.9 million. Paced to hit over $225 million in full-year 2022 revenues, the Company is also taking steps to become fully reporting and to uplist to a major exchange.

“We filed the Form 10K and we'll have a steppingstone to the OTCQB or the OTCQX for a while as we solidify the management team, grow the revenues and check out the market conditions,” Massey explains. “I think 2023 NASDAQ is definitely in the picture, but again, the market conditions are very important for that step.”

As SIRC moves toward its operational and financial goals, the Company is aligning its management team with its potential. Earlier this month, SIRC named Stefan Abbruzzese as its new president. An experienced operations and commercial leader with decades of experience, Abbruzzese will provide extensive knowledge to SIRC’s expansion.

“He's a topnotch executive,” Massey says. “Our second focus this year is getting the correct funding in place so we can continue to grow and move our pipeline, and Abbruzzese is an expert in lending. He brings a lot of expertise and experience in that field and and is just a great leader.”

SIRC intends to move into the coming year with the funding, cashflow and revenue growth it needs to surpass its already historic corporate performance.

“We're looking to wrap up our funding process … and get cashflow positive. We're very close to that now, and we're looking to really blow the doors off the revenue this year,” Massey says, noting his expectations for continued revenue growth. “Looking forward, 2023 could be twice as good as 2022.”

SmallCapVoice.com, Inc. (“SCV”) today announces the availability of a new interview with Marc Hazout, CEO of SusGlobal Energy Corp. (OTCQB: SNRG) (“the Company”), to discuss the Company’s milestone achievement in generating revenues from its carbon credits monetization initiative.

As Leaders in the Circular Economy ®, SusGlobal is focused on reducing greenhouse gases and diverting organic waste streams from landfills, processing them into regenerative products such as fertilizer. As reported in September, the Company’s SusGlobal Belleville subsidiary has generated roughly 105,000 Verified Emission Reductions and Removals (VERRs) and recently sold its first carbon credits, adding to SusGlobal a third revenue stream.

The sales will be reflected in SusGlobal’s upcoming third-quarter earnings Hazout tells SCV’s Stuart Smith, and the Company anticipates repeating this financial milestone annually. He also notes additional near-term corporate objectives, including uplisting to the NASDAQ and advancing its Hamilton processing facility to achieve a similar revenue pattern.

“It is very exciting times at the Company, and I think the market reflects that,” Hazout says. “I think we're seeing the valuation continue to increase incrementally … We have the capacity to increase the amount of tonnage that we're processing and therefore it will reflect in an increase of carbon credits, we're able to generate more VERRs. When Hamilton is online in 2023, we'll register that facility to do the same thing and repeat it. We now have the expertise to do that.”

AUSTIN, Texas (Sept. 21, 2022) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Ryan Schadel, CEO of Metavesco Inc. (OTC PINK: MVCO) (“the Company”), a web3 enterprise invested in decentralized finance (DeFi), to discuss the Company’s operations, digital assets and corporate outlook.

The full interview can be heard at: https://www.smallcapvoice.com/2022-interview-mvco-metavesco-mvco/.

Speaking with SCV’s Stuart Smith, Schadel explains how Metavesco generates revenues through liquidity pools alongside its focus on crypto staking, NFT and the Metaverse.

“There's so much being built in this space and we're trying to cast a wide net and capture what we can as this space matures and becomes more mainstream,” he says, offering insight into the broader crypto market and what the Company expects to achieve from its investments and position as an early mover.

“When I look at 2023, it's really about a year of mass adoption. I think we will see the protocols that we've invested in achieve wider adoption rates. I believe that next year we will see some pretty significant returns in the money that we've put to work and that will ultimately benefit shareholders,” he says. “There is no other publicly traded cryptocurrency liquidity provider in the United States; we are the first and I'm certain we won't be the last. That means we have some proving to do, and so my hope for next year is that when shareholders and potential shareholders look at how we did, they think ‘Wow, this model is great. Metavesco is really a first-mover and is generating returns for shareholders.’ Ultimately, that’s my job.”

AUSTIN, Texas (Sept. 20, 2022) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Yftah Ben Yaackov, CEO of BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (CNSX:BYND.CN) (“BYND” or the “Company”), to discuss the Company’s operations, innovations and outlook for the coming year.

The full interview can be heard at: https://www.smallcapvoice.com/2022-interview-bynd-cannasoft-bcan/.

BYND is an Israel-based integrated software/cannabis company focused on the development of its customer relationship management (CRM) platform for the medical cannabis market. Speaking with SCV’s Stuart Smith, Ben Yaackov discusses the Company’s 20 years in the big data market and the decision to extend its expertise to growers, suppliers and researchers of medicinal cannabis.

“BYND made a strategic decision about two years ago to try to arrange a software that will solve many problems that growers of medical cannabis have. Currently in the final stage of development, the software manages databases while integrating algorithm for maximizing and streamlining growing farms in general, and particularly medical cannabis farms,” he says.

A professional lawyer since 2004, Ben Yaackov also has experience in project management and trading in medicinal cannabis. This combination has resulted in several corporate achievements and provides support for BYND’s objectives moving forward.

“2020, 2021 and the first half of 2022 were challenging and exciting at the same time,” he explains, highlighting BYND’s listing on the Canadian CSE and NASDAQ capital markets earlier this year.

The Company also recently acquired an Israel-based company with a patent-pending CBD treatment product, the EZ-G device, representing a $28 million transaction that Ben Yaackov says will add value to BYND as it seeks regulatory approval and patent registration.

The EZ-G device uses proprietary software (provisional application) to regulate the flow of low-concentration CBD oils into the soft tissues of the female reproductive system to treat candida, dryness, scars and other health issues.

“This, together with our great development in the software field and the preparations of obtaining the license to practice medical cannabis, makes the last two years a period of great prosperity and success,” he adds. “We are confident that it will bring significant value for the Company in the upcoming year.”

Wrapping up 2022 and moving into 2023, Ben Yaackov says he expects to see continued progress in the Company’s software development and sales expansion. Additionally, BYND is in the final stage of obtaining a license to engage in the sale of medical cannabis without connecting with the substance.

“This is a special license that few have in Israel. It allows you to establish products in the medical cannabis field, a label of your own, through an existing grower that has the license to grow medical cannabis in Israel,” he explains. “That will bring us another revenue from the side of selling medical cannabis products, and above all that, I believe that we will significantly advance the new project and finish the patent registration and put other necessary regulations and build a prototype until the end of the fourth quarter of 2023.”

CEO, Cliff Emmons, and COO, Karen McNemar discuss the recently announced financial results for its second quarter ended June 30, 2022.

Cliff Emmons, CEO of IIOT-OXYS, Inc. (Oxys) stated, "Our revenue for the quarter ended June 30, 2022 exceeded the total revenue for 2021, as was anticipated in our Quarterly Report on Form 10-Q for the first quarter of 2022. We continue to gain traction with strategic partners, customers, and potential customers in our key two markets: Smart Manufacturing / Industry 4.0 and Structural Health Monitoring (SHM). These are both high growth markets. Market research shows the worldwide Industry 4.0 market in 2021 was $64.9 billion USD and is projected to be $165.5 billion USD by 2026 (20.6% CAGR).1 Also, the worldwide Structural Health Monitoring industry was $2.0 billion USD in 2021 and will reach $4.0 billion USD by 2027 (CAGR of 14.6%).2 Through our collaborations with Aretas Sensor Networks, we have access to a third market, Indoor Air Quality Monitors, which was estimated at $3.7 billion USD in 2020 and projected to reach $6.4 billion USD in 2027, growing at 8.2% CAGR.3"

Some Key Accomplishments in 2022 YTD include:

Our Structural Health Monitoring business continues to gather momentum, receiving a contract extension with a New England State's DOT for Bridge Monitoring announced in the first quarter for monitoring throughout the second quarter, which generated this quarter's revenue. A proposal for monitoring and equipment upgrades for the 2022 to 2023 fiscal year was submitted in the second quarter, and we anticipate its formal approval in the second half of 2022. We received verbal approval to continue invoicing monitoring fees into third quarter, while awaiting formal written approval.

The Canadian Indoor Air Quality Sensor and IIoT Platform company, Aretas Sensor Networks, with whom we entered an NDA in the first quarter, continues to progress well. In addition to the initial collaborative agreement signed in the first quarter, we signed an algortihm development contract in the second quarter which will generate revenue in our third quarter. We continue to explore additional collaborations that we expect to move forward with this year.

Our CEO, Cliff Emmons, and COO, Karen McNemar, both renewed their employment contracts in June, ensuring stable experienced leadership focused on long-term growth.

"We believe the underlying strengths of the Company are gathering momentum for expected growth. We will keep a steady focus on prospecting, submitting proposals, and securing Proof of Concepts (POCs). It is anticipated that the momentum of the second quarter's revenue will continue into the third quarter and the second half of the year. We expect that our third quarter revenue will match or exceed this quarter's revenues, and revenue for the second half of 2022 will exceed that generated in the first half of 2022. In total, we expect that total revenue for 2022 will exceed that of 2019" concluded Mr. Emmons.

MIAMI, FL, Aug. 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company (the “Company” or “Progressive Care”), is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Thursday, August 11, 2022.

Chairman and CEO, Alan Jay Weisberg, stated, “We are looking forward to updating you on the results of the second quarter, our prescription growth, and recent developments that we believe will continue to accelerate our growth as a diversified technology-centric healthcare organization”.

AUSTIN, Texas (August 2nd, 2022) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Nika Jaksic, COO of BioLife Sciences Inc. (OTCPK: BLFE) (the “Company”), to provide an overview of the Company’s operations and corporate momentum. The interview includes discussion on BioLife’s plans for uplitsing and its upcoming launch of an innovative product to improve cannabis cultivation.

BioLife is a commercialization accelerator focused on moving innovative products from the lab to small scale production while also conceptualizing and innovating its own line of products. Speaking with SCV’s Stuart Smith, Jaksic explains how the Company’s wide approach to this model creates unrestrictive market opportunity.

“We like to take disruptive ideas and grow and expand those ideas into marketable products that aim to enrich the lives of our customers and our communities, whether that's a new concept being developed from scratch, or simply us reinventing the wheel,” he says. “We're not going to limit ourselves to any one product or any one industry. If we have a marketable idea that will help our customers and benefit our shareholders, then we will pursue.”

Jaksic next describes how a corporate transformation, brought-on by a leadership change in 2020, has enhanced business development. This growth includes an acquisition strategy that enables the introduction of new and innovative products to the market. As the Company advances on these opportunities, it is now prepared to broaden its exposure to the investment community.

“Uplisting to the OTCQB has traditionally resulted in greater liquidity, increased transparency, upgraded reporting standards, better overall awareness of the company to our larger group of investors, including venture capitalists,” he says. “Aside from that, we are going to continue developing our new natural health products division so we can keep expanding our company and its offerings in the coming years. And of course, we're going to introduce new and exciting products to the marketplace so we can increase the Company's revenue. We're excited about what the future holds for our Company and its shareholders.”

A high-potential aspect of BioLife’s future pivots from its acquisition of Health Box LLC, a health products company founded by Jaksic in 2020, along with a new focus on copper-infused textiles.

“When I say we ‘reinvent the wheel,’ that is exactly what we accomplished with our copper infusion process and the resulting line of product,” Jaksic says, explaining how the COVID-19 pandemic generated greater demand for products utilizing copper’s antimicrobial properties. While there are many copper-infused textiles in the market, BioLife distanced itself from competitors by offering superior and innovative copper-infused textiles.

The root innovation is the Company’s unique copper infusion process, which significantly improves copper distribution throughout the fibers of the fabric while reducing costs and time.

“We can use infusion in the traditional way to design our copper-infused garments from scratch … or we can do it by obtaining preexisting garments and infusing them with copper after they have been designed,” Jaksic says. This capability enables BioLife to pursue partnerships with other companies that want to improve the quality and efficacy of their products beyond industry standards.

Based on this technology, the Company intends to initiate three novel product launches within the next year, starting with an antimicrobial copper-infused fabric gardening pot. This product launch will position the Company before a new market of customers in the $300+ billion global cannabis cultivation market.

“The copper works as a fungicide that eliminates harmful microbes while simultaneously boosting the beneficial organisms that thrive in the soil. The results are healthier and stronger plants with larger yields as well as healthier soil,” Jaksic explains. “Our main target demographic will be cannabis cultivators due to the unique growing requirements of cannabis. Cannabis farmers are keenly aware of the benefits of fabric pots. We will vigorously pursue the cannabis cultivator market, but we will additionally focus on farmers, agricultural professionals, home gardeners, landscapers, nurseries and some industrial gardening organizations.”

SmallCapVoice.com Inc. ("SCV") announces the availability of a new interview with Rhett Doolittle to discuss the recent Q3 results for Business Warrior Corp.'s (OTC PINK:BZWR) ("the Company") and the driver's for success moving forward. He is joined by Business Warrior's Global Head of Technology Timothy Li who provides he unique insights as the newest member of the BZWR team.

Business Warrior is a SaaS company providing small businesses in the United States with a suite of data-driven marketing and next-generation, funding solutions to boost local market dominance. Founded in 2014, Business Warrior is singularly focused on offering locally targeted lead generation marketing and funding solutions that fuel small business growth. By using next generation machine-learning and native software, Business Warrior has made growth funding and conversion marketing accessible for thousands of under-resourced and under-funded small business owners. For more information, visit BusinessWarrior.com.

SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Dr. Bill Williams, CEO of BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT), to discuss key achievements that support the Company’s continued growth and his recent purchase of the Company's warrants.

BriaCell is a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer. Speaking with SCV’s Stuart Smith, Dr. Williams first detailed his reasoning behind the purchase of his Company's stock. Williams stated, "With my training in immunology and extensive background in the field, I have already seen technologies worth paying attention to, and I know what we have here at BriaCell is something very special."

Dr. Williams also discussed the recent news regarding the manufacturing service agreement with Waisman Biomanufacturing at the University of Wisconsin–Madison (Waisman), to manufacture Bria-Pros, BriaCell’s off-the-shelf personalized immunotherapy for prostate cancer, and the collaboration agreement with Harvard Medical School in support of a project led by Dr. Joan S. Brugge attempting to discover new targets that may lead to the development of novel anti-cancer treatments.